10/02/2026
Did you experience sudden vision loss after taking Ozempic, Wegovy, Mounjaro, Zepbound or another GLP-1 medication?
Researchers have identified a potential association between certain GLP-1 medications and NAION, a serious optic-nerve injury that can cause sudden and permanent vision loss.
Federal lawsuits are now underway, and the FDA has identified NAION as a potential safety concern involving GLP-1 medications.
If you or someone you know suffered significant vision loss after using a GLP-1 medication, learn what the developing science and federal litigation may mean for a potential claim.
Smith McBroom is evaluating GLP-1 vision-loss and NAION claims.
Experienced sudden or permanent vision loss after Ozempic, Wegovy, Mounjaro, Zepbound or another GLP-1 drug? Learn about NAION lawsuits, current research and potential legal claims.